Medicines Amendment Regulations 2020

2020/262

Coat of Arms of New Zealand

Medicines Amendment Regulations 2020

Patsy Reddy, Governor-General

Order in Council

At Wellington this 21st day of September 2020

Present:
The Right Hon Jacinda Ardern presiding in Council

These regulations are made under section 105 of the Medicines Act 1981,—

(a)

on the advice and with the consent of the Executive Council; and

(b)

on the advice of the Minister of Health given in accordance with that section.

Regulations

1 Title

These regulations are the Medicines Amendment Regulations 2020.

2 Commencement

These regulations come into force on 30 September 2020.

3 Principal regulations

These regulations amend the Medicines Regulations 1984 (the principal regulations).

4 Regulation 4A amended (Standard for CBD products)

In regulation 4A(4), replace “during the 6-month period that starts at the commencement of this regulation” with “until 1 April 2021”.

Michael Webster,
Clerk of the Executive Council.

Explanatory note

This note is not part of the regulations, but is intended to indicate their general effect.

These regulations, which come into force on 30 September 2020, amend the Medicines Regulations 1984. The amendment to regulation 4A(4) provides a 6-month extension to the transitional period during which there is an exemption to the minimum quality standard applying to the product of a licence-holder. That transitional period now ends on 31 March 2021 and the minimum quality standard will apply on and after 1 April 2021.

Issued under the authority of the Legislation Act 2012.

Date of notification in Gazette: 24 September 2020.

These regulations are administered by the Ministry of Health.